193 related articles for article (PubMed ID: 35682850)
41. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis.
Fearnhead NS; Wilding JL; Bodmer WF
Br Med Bull; 2002; 64():27-43. PubMed ID: 12421723
[TBL] [Abstract][Full Text] [Related]
42. RPS24c Isoform Facilitates Tumor Angiogenesis
Wang Y; Wu Y; Xiao K; Zhao Y; Lv G; Xu S; Wu F
Curr Mol Med; 2020; 20(5):388-395. PubMed ID: 31797757
[TBL] [Abstract][Full Text] [Related]
43. Role of ribosomal protein mutations in tumor development (Review).
Goudarzi KM; Lindström MS
Int J Oncol; 2016 Apr; 48(4):1313-24. PubMed ID: 26892688
[TBL] [Abstract][Full Text] [Related]
44. Outcome of colorectal cancer in Diamond-Blackfan syndrome with a ribosomal protein S19 mutation.
Kimura K; Shimazu K; Toki T; Misawa M; Fukuda K; Yoshida T; Taguchi D; Fukuda S; Iijima K; Takahashi N; Ito E; Nanjyo H; Shibata H
Clin J Gastroenterol; 2020 Dec; 13(6):1173-1177. PubMed ID: 32643123
[TBL] [Abstract][Full Text] [Related]
45. Transcriptome analysis of paired primary colorectal carcinoma and liver metastases reveals fusion transcripts and similar gene expression profiles in primary carcinoma and liver metastases.
Lee JR; Kwon CH; Choi Y; Park HJ; Kim HS; Jo HJ; Oh N; Park do Y
BMC Cancer; 2016 Jul; 16():539. PubMed ID: 27461012
[TBL] [Abstract][Full Text] [Related]
46. High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumors.
Ferreira AM; Tuominen I; van Dijk-Bos K; Sanjabi B; van der Sluis T; van der Zee AG; Hollema H; Zazula M; Sijmons RH; Aaltonen LA; Westers H; Hofstra RM
Hum Mutat; 2014 Dec; 35(12):1442-5. PubMed ID: 25196364
[TBL] [Abstract][Full Text] [Related]
47. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
[TBL] [Abstract][Full Text] [Related]
48. Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.
Mur P; Jemth AS; Bevc L; Amaral N; Navarro M; Valdés-Mas R; Pons T; Aiza G; Urioste M; Valencia A; Lázaro C; Moreno V; Puente XS; Stenmark P; Warpman-Berglund U; Capellá G; Helleday T; Valle L
Hum Mutat; 2018 Sep; 39(9):1214-1225. PubMed ID: 29900613
[TBL] [Abstract][Full Text] [Related]
49. miR-608 rs4919510 Polymorphism May Affect Susceptibility to Colorectal Cancer by Upregulating
Zhu X; Liu Y; Xu J; Cheng Z; Yu Y; Chu M; Lu X; Yuan W
DNA Cell Biol; 2020 Nov; 39(11):2017-2027. PubMed ID: 33147064
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations.
Kraus C; Rau TT; Lux P; Erlenbach-Wünsch K; Löhr S; Krumbiegel M; Thiel CT; Stöhr R; Agaimy A; Croner RS; Stürzl M; Hohenberger W; Hartmann A; Reis A
Int J Cancer; 2015 Mar; 136(6):E559-68. PubMed ID: 25142776
[TBL] [Abstract][Full Text] [Related]
51. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
[TBL] [Abstract][Full Text] [Related]
52. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.
Normanno N; Rachiglio AM; Lambiase M; Martinelli E; Fenizia F; Esposito C; Roma C; Troiani T; Rizzi D; Tatangelo F; Botti G; Maiello E; Colucci G; Ciardiello F;
Ann Oncol; 2015 Aug; 26(8):1710-4. PubMed ID: 25851630
[TBL] [Abstract][Full Text] [Related]
54. Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients.
Tsoi H; Lam KC; Dong Y; Zhang X; Lee CK; Zhang J; Ng SC; Ng SSM; Zheng S; Chen Y; Fang J; Yu J
Oncogene; 2017 Nov; 36(44):6109-6118. PubMed ID: 28692053
[TBL] [Abstract][Full Text] [Related]
55. Small and Large Ribosomal Subunit Deficiencies Lead to Distinct Gene Expression Signatures that Reflect Cellular Growth Rate.
Cheng Z; Mugler CF; Keskin A; Hodapp S; Chan LY; Weis K; Mertins P; Regev A; Jovanovic M; Brar GA
Mol Cell; 2019 Jan; 73(1):36-47.e10. PubMed ID: 30503772
[TBL] [Abstract][Full Text] [Related]
56. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of the Ribosomal Protein eL29 in Mammalian Cells Leads to Significant Changes in Gene Expression at the Transcription Level.
Gopanenko AV; Kolobova AV; Meschaninova MI; Venyaminova AG; Tupikin AE; Kabilov MR; Malygin AA; Karpova GG
Cells; 2020 May; 9(5):. PubMed ID: 32429214
[TBL] [Abstract][Full Text] [Related]
58. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.
Casey G; Lindor NM; Papadopoulos N; Thibodeau SN; Moskow J; Steelman S; Buzin CH; Sommer SS; Collins CE; Butz M; Aronson M; Gallinger S; Barker MA; Young JP; Jass JR; Hopper JL; Diep A; Bapat B; Salem M; Seminara D; Haile R;
JAMA; 2005 Feb; 293(7):799-809. PubMed ID: 15713769
[TBL] [Abstract][Full Text] [Related]
59. The human ribosomal protein eL29 binds in vivo to the cognate mRNA by interacting with its coding sequence, as revealed from in-cell cross-linking data.
Babaylova ES; Kolobova AV; Gopanenko AV; Tupikin AE; Kabilov MR; Malygin AA; Karpova GG
Biochimie; 2020 Oct; 177():68-77. PubMed ID: 32798643
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
Escobar D; Bushara O; Sun L; Liao J; Yang GY
Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
